全文获取类型
收费全文 | 7132篇 |
免费 | 478篇 |
国内免费 | 24篇 |
专业分类
耳鼻咽喉 | 96篇 |
儿科学 | 462篇 |
妇产科学 | 84篇 |
基础医学 | 878篇 |
口腔科学 | 244篇 |
临床医学 | 499篇 |
内科学 | 1632篇 |
皮肤病学 | 123篇 |
神经病学 | 500篇 |
特种医学 | 196篇 |
外科学 | 893篇 |
综合类 | 184篇 |
一般理论 | 1篇 |
预防医学 | 410篇 |
眼科学 | 128篇 |
药学 | 551篇 |
中国医学 | 62篇 |
肿瘤学 | 691篇 |
出版年
2023年 | 36篇 |
2022年 | 79篇 |
2021年 | 260篇 |
2020年 | 131篇 |
2019年 | 177篇 |
2018年 | 198篇 |
2017年 | 142篇 |
2016年 | 171篇 |
2015年 | 179篇 |
2014年 | 261篇 |
2013年 | 359篇 |
2012年 | 550篇 |
2011年 | 520篇 |
2010年 | 293篇 |
2009年 | 236篇 |
2008年 | 366篇 |
2007年 | 369篇 |
2006年 | 330篇 |
2005年 | 325篇 |
2004年 | 288篇 |
2003年 | 263篇 |
2002年 | 230篇 |
2001年 | 173篇 |
2000年 | 184篇 |
1999年 | 175篇 |
1998年 | 80篇 |
1997年 | 63篇 |
1996年 | 44篇 |
1995年 | 51篇 |
1994年 | 36篇 |
1993年 | 33篇 |
1992年 | 108篇 |
1991年 | 85篇 |
1990年 | 87篇 |
1989年 | 88篇 |
1988年 | 72篇 |
1987年 | 62篇 |
1986年 | 56篇 |
1985年 | 53篇 |
1984年 | 50篇 |
1983年 | 44篇 |
1982年 | 24篇 |
1981年 | 22篇 |
1979年 | 39篇 |
1978年 | 26篇 |
1975年 | 17篇 |
1974年 | 22篇 |
1973年 | 22篇 |
1971年 | 17篇 |
1970年 | 22篇 |
排序方式: 共有7634条查询结果,搜索用时 15 毫秒
1.
2.
3.
Lesley A. Inker Morgan E. Grams Andrew S. Levey Josef Coresh Massimo Cirillo John F. Collins Ron T. Gansevoort Orlando M. Gutierrez Takayuki Hamano Gunnar H. Heine Shizukiyo Ishikawa Sun Ha Jee Florian Kronenberg Martin J. Landray Katsuyuki Miura Girish N. Nadkarni Carmen A. Peralta Dietrich Rothenbacher Mark Woodward 《American journal of kidney diseases》2019,73(2):206-217
4.
Clinical Rheumatology - Our aim was to determine reasons for admission, the prevalence and spectrum of infections, and the outcomes in a multiethnic cohort of hospitalized systemic lupus... 相似文献
5.
6.
Girish S. Mishra Arpan Bhatia 《Indian journal of otolaryngology and head and neck surgery》2007,59(3):296-297
Dermatofibrosarcoma protuberance of head and neck is a rare neoplasm and accounts for less than one percent of Head and Neck Neoplasm. The objective of this report is to understand etiology, presentation, histopathologic identification and treatment option for this tumour. The goal of current report is to acquaint the clinician with presentation and treatment option for this disease. 相似文献
7.
Duct-associated lymphoid tissue (DALT) of minor salivary glands and mucosal immunity. 总被引:3,自引:0,他引:3 下载免费PDF全文
Minor salivary glands (MSG) play a substantial role in the secretory immunoglobulin A (sIgA)-mediated immunity of the oral cavity. There are two possibilities for the induction of this immunity: (i) an explicitly local antigenic stimulus, or (ii) a remote stimulus as part of the so-called 'common mucosal immune system'. This communication is an attempt to consolidate available evidence in support of both possibilities and to address the former in detail. Although there is strong circumstantial evidence supporting the feasibility of MSG functioning as a part of the common mucosal immune system, direct experimental evidence is yet to emerge. On the other hand, there is increasing structural and physiological evidence in support of MSG serving as a local immunological organ. The purely local response is attributed to the presence of MSG duct-associated lymphoid tissue (DALT), which is comparable to gut- or bronchial-associated lymphoid tissue (GALT or BALT) in origin, tissue organization and function. DALT is accessible to oral antigens by retrograde passage through MSG ducts. Repeated topical antigenic challenging via the oral mucosa may result in the appearance of interacinar plasma cells carrying specific homologous antibodies in MSG. Gut or enteric priming of the same antigen, by passing the oral mucosa by gastric intubation, need not evoke a remote immune response in MSG. Since DALT is more likely to occur in healthy, young growing individuals, who are less likely to undergo bioptic examination of MSG, it has not yet been documented in humans. The physiologically induced DALT is apt to be confused with focal accumulations of lymphoid tissue in pathologically altered MSG, as a consequence of local and some systemic autoimmune diseases. An attempt is made to demarcaate healthy and pathological MSG on the basis of currently available clinical, serological, immunological and genetic evidence. 相似文献
8.
Weiss Robert A. MD McDaniel David H. MD † Geronemus Roy G. MD ‡ MARGARET A. WEISS MD KAREN L. BEASLEY MD § Munavalli Girish M. MD§ § Bellew Supriya G. MD ¶ 《Dermatologic surgery》2005,31(S3):1199-1205
Background. Light-emitting diode (LED) photomodulation is a novel nonthermal technology used to modulate cellular activity with light.
Objective:. We describe our experience over the last 2 years using 590 nm LED photomodulation within a dermatologic surgery environment.
Methods. Practical use of nonthermal light energy and emerging applications in 3,500 treatments delivered to 900 patients is detailed.
Results. LED photomodulation has been used alone for skin rejuvenation in over 300 patients but has been effective in augmentation of results in 600 patients receiving concomitant nonablative thermal and vascular treatments such as intense pulsed light, pulsed dye laser, KTP and infrared lasers, radiofrequency energy, and ablative lasers.
Conclusion:. LED photomodulation reverses signs of photoaging using a new nonthermal mechanism. The anti-inflammatory component of LED in combination with the cell regulatory component helps improve the outcome of other thermal-based rejuvenation treatments. 相似文献
Objective:. We describe our experience over the last 2 years using 590 nm LED photomodulation within a dermatologic surgery environment.
Methods. Practical use of nonthermal light energy and emerging applications in 3,500 treatments delivered to 900 patients is detailed.
Results. LED photomodulation has been used alone for skin rejuvenation in over 300 patients but has been effective in augmentation of results in 600 patients receiving concomitant nonablative thermal and vascular treatments such as intense pulsed light, pulsed dye laser, KTP and infrared lasers, radiofrequency energy, and ablative lasers.
Conclusion:. LED photomodulation reverses signs of photoaging using a new nonthermal mechanism. The anti-inflammatory component of LED in combination with the cell regulatory component helps improve the outcome of other thermal-based rejuvenation treatments. 相似文献
9.
R Nair K Prabhash M Sengar A Bakshi S Gujral S Gupta P Parikh 《Annals of oncology》2007,18(7):1243-1245
BACKGROUND: Various malignancies and cytotoxic chemotherapy have been proposed to increase the risk of reactivation of tuberculosis. Available literature to support this observation is still conflicting. There is scarcity of data from countries with rampant tubercular infection, such as India, in this regard. DESIGN AND METHODS: In the present retrospective analysis, patients with high-grade non-Hodgkin's lymphoma with past history of tuberculosis and have had adequate antitubercular therapy were identified from a Lymphoma Group study. These patients were followed up during cytotoxic chemotherapy and later to assess the risk of reactivation. RESULTS: A cohort of eight patients with past history of tuberculosis was selected from 141 patients of high-grade non-Hodgkin's lymphoma. The median age was 33.5 years (range, 24-53 years). Median duration between completion of antitubercular treatment and diagnosis of lymphoma was 5 years (range, 1.5-10 years). All patients received cyclical cytotoxic chemotherapy. The median duration of follow up after completion of chemotherapy was 5 years (range, 10 months to 5 years). None of these patients developed reactivation of tuberculosis. CONCLUSION: Cyclical chemotherapy for non-Hodgkin's lymphoma does not lead to reactivation of tuberculosis. 相似文献
10.
A Abraham M G Nair R L Kisliuk Y Gaumont J Galivan 《Journal of medicinal chemistry》1990,33(2):711-717
Representative examples of folate and antifolate poly-gamma-glutamyl metabolites were synthesized via the [(9-fluorenylmethoxy)oxy]carbonyl (Fmoc) chemistry using the KH polyamide resin. Polyglutamate yields were consistently better in all cases compared to the previous Merrifield method, and the crude products were obtained in greater than 85% purity. The symmetrical anhydride (7) derived from alpha-tert-butyl N-Fmoc-L-glutamate (6) was used for the initial coupling of the first glutamate residue to the KH resin and also for subsequent chain elongation. The alpha-tert-butyl protective groups were not labile under the conditions used for the cleavage of the finished peptide from the resin. A series of poly-gamma-glutamyl metabolites of methotrexate (MTX) with a chain length ranging from two to five glutamyl residues were synthesized and coupled with poly(L-lysine) having an average molecular weight of 27,000 and 52,000. Each conjugate was tested for its ability to inhibit the growth of wild type (H35) and MTX transport resistant (H35R) strains of hepatoma cells in culture, the latter having a 100-fold reduced sensitivity to MTX. 4-Amino-4-deoxy-N10-methylpteroylglutamyl-gamma-glutamylpoly (L-lysine) conjugate [MTX(G2)-poly-L-Lys-52000] and MTX(G4)-poly-L-Lys-52000 were among the most active (I50 = 8.0 and 10 nM against H35 cells) MTX-polylysines synthesized to date, and they were somewhat more inhibitory to the transport resistant cells. MTX(G5)-poly-L-Lys-52000 was approximately 1000 times more effective than MTX(G5)-poly-D-Lys-52000 in inhibiting the growth of H35R hepatoma cells in culture, indicating that internal cleavage of the gamma-glutamate chain of the conjugate with subsequent release of MTX or shorter chain polyglutamates of MTX is unlikely to be an important determinant of MTX-polyglutamate polylysine cytotoxicity. The results indicate that MTX-polyglutamate poly(L-lysine) conjugates are taken up by the cells independently of MTX and probably via endocytosis. 相似文献